Personalis paid its 3 named executives $6.7M in total in FY2025 (Dec). CEO Christopher Hall was paid $3.5M of that.
Pay$100 in the stock at the end of FY21 → $56
Pay of each named executive
Christopher HallChief Executive Officer and Director
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Aaron TachibanaChief Financial Officer and Chief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Richard Chen, M.D., M.S.President, Executive Vice President, Research and Development and Chief Medical Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 3 peers with pay on file was $4.3M. The CEO of Personalis was paid $3.5M, 19% below the median.
- 1GeneDx Holdings
- 2Pacific Biosciences Of California
- 3PersonalisThis company
- 4Outset Medical
- 5Adaptive Biotechnologies1Not disclosed
- 6Akoya Biosciences1Not disclosed
- 7Alector1Not disclosed
- 8BiodesixNot disclosed
- 9CareDx1Not disclosed
- 10Castle Biosciences1Not disclosed
- 11Codexis1Not disclosed
- 12CytomX Therapeutics1Not disclosed
- 13Fulgent Genetics1Not disclosed
- 14Mesa Laboratories1Not disclosed
- 15Nautilus BiotechnologyNot disclosed
- 16OraSure TechnologiesNot disclosed
- 17Quanterix1Not disclosed
- 18Seer1Not disclosed
- 19Standard BioTools1Not disclosed
- 20Sutro Biopharma1Not disclosed
- 21Twist Bioscience1Not disclosed
- 22Veracyte1Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.